Neoplasia (Oncolytic virus)

Fighting cancer with oncolytic viruses.
[16424499] BMJ 332(7534): 170-2 (2006)

Oncolytic viruses: time to compare, contrast, and combine? 5th international meeting on replicating oncolytic virus therapeutics. Banff, Alberta, Canada, 18-22 March 2009.
[19483767] Mol Ther 17(6): 934-5 (2009)

Cytolytic viruses as potential anti-cancer agents.
[11842243] J Gen Virol 83(Pt 3): 491-502 (2002)

The emergence of combinatorial strategies in the development of RNA oncolytic virus therapies.
[19388908] Cell Microbiol 11(6): 889-97 (2009)

Targeting gene-virotherapy of cancer.
[16467873] Cell Res 16(1): 25-30 (2006)

Gene therapy progress and prospects cancer: oncolytic viruses.
[18418413] Gene Ther 15(12): 877-84 (2008)

Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions.
[17234747] Cancer Res 67(2): 429-32 (2007)

Viral oncolysis by herpes simplex virus and other viruses.
[15917655] Cancer Biol Ther 4(5): 524-31 (2005)

The oncolytic virotherapy treatment platform for cancer: unique biological and biosafety points to consider.
[12522445] Cancer Gene Ther 9(12): 1062-7 (2002)

Biosafety and product release testing issues relevant to replication-competent oncolytic viruses.
[12522444] Cancer Gene Ther 9(12): 1056-61 (2002)

Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes.
[12522441] Cancer Gene Ther 9(12): 1022-35 (2002)

Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers.
[12522439] Cancer Gene Ther 9(12): 1001-12 (2002)

Oncolytic herpes simplex virus vectors for cancer virotherapy.
[12522436] Cancer Gene Ther 9(12): 967-78 (2002)

Oncolytic herpes simplex virus therapy for peripheral nerve tumors.
[17613221] Neurosurg Focus 22(6): E4 (2007)

Oncolytic adenoviral therapy for glioblastoma multiforme.
[16709024] Neurosurg Focus 20(4): E19 (2006)

Recent developments in the virus therapy of cancer.
[10654614] Proc Soc Exp Biol Med 223(2): 118-27 (2000)

Feasibility of herpes simplex virus type 1 mutants labeled with radionuclides for tumor treatment.
[18322942] World J Gastroenterol 14(9): 1321-5 (2008)

Getting oncolytic virus therapies off the ground.
[12892708] Cancer Cell 4(1): 7-11 (2003)

Newcastle disease virus as an oncolytic agent.
[20090097] Indian J Med Res 130(5): 507-13 (2009)

A novel molecular therapy using bioengineered adenovirus for human gastrointestinal cancer.
[21709712] Acta Med Okayama 65(3): 151-62 (2011)

Cancer-specific viruses and the development of ONYX-015.
[14508094] Cancer Biol Ther 2(4 Suppl 1): S157-60 (2003)

Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses.
[18328829] Biochim Biophys Acta 1785(2): 217-31 (2008)

Selective anticancer strategies via intervention of the death pathways relevant to cell transformation.
[18437165] Cell Death Differ 15(8): 1197-210 (2008)

Eradication of brain tumor stem cells with an oncolytic adenovirus.
[20670595] Discov Med 10(50): 24-8 (2010)

Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.
[21034670] Discov Med 10(53): 293-304 (2010)

Oncolytic virotherapy for neuroblastoma.
[21122470] Discov Med 10(54): 387-93 (2010)

Use of replicating oncolytic adenoviruses in combination therapy for cancer.
[15328165] Clin Cancer Res 10(16): 5299-312 (2004)

ONYX-015: mechanisms of action and clinical potential of a replication-selective adenovirus.
[11857003] Br J Cancer 86(1): 5-11 (2002)

Oncolytic herpes simplex virus vectors and chemotherapy: are combinatorial strategies more effective for cancer?
[20373873] Future Oncol 6(4): 619-34 (2010)

Viruses in the treatment of malignant glioma.
[17425484] Expert Rev Neurother 7(4): 321-4 (2007)

Oncolytic viruses: extreme treatment for an extreme disease.
[17661625] Future Microbiol 1(4): 351-3 (2006)

Translational research in oncolytic measles virotherapy: early discoveries and future steps.
[21366411] Future Microbiol 6(2): 125-8 (2011)

Virotherapy against malignant glioma stem cells.
[19643532] Cancer Lett 289(1): 1-10 (2010)

Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus.
[20211576] Cytokine Growth Factor Rev 21(2-3): 169-75 (2010)

Directing systemic oncolytic viral delivery to tumors via carrier cells.
[20226717] Cytokine Growth Factor Rev 21(2-3): 119-26 (2010)

Preparing an oncolytic poliovirus recombinant for clinical application against glioblastoma multiforme.
[20299272] Cytokine Growth Factor Rev 21(2-3): 197-203 (2010)

Impact of tumor microenvironment on oncolytic viral therapy.
[20399700] Cytokine Growth Factor Rev 21(2-3): 127-34 (2010)

Oncolytic viruses: a novel form of immunotherapy.
[18925850] Expert Rev Anticancer Ther 8(10): 1581-8 (2008)

[A mini-review of targeting gene-virotherapy of cancer].
[17059786] Ai Zheng 25(10): 1320-2 (2006)

Enhancing mda-7/IL-24 therapy in renal carcinoma cells by inhibiting multiple protective signaling pathways using sorafenib and by Ad.5/3 gene delivery.
[20948318] Cancer Biol Ther 10(12): 1290-305 (2011)

The antitumor efficacy of IL-24 mediated by E1A and E1B triple regulated oncolytic adenovirus.
[20574150] Cancer Biol Ther 10(3): 242-50 (2010)

Eradication of therapy-resistant human prostate tumors using a cancer terminator virus.
[17545625] Cancer Res 67(11): 5434-42 (2007)

Molecular target-based therapy of pancreatic cancer.
[16489047] Cancer Res 66(4): 2403-13 (2006)

Unique conditionally replication competent bipartite adenoviruses-cancer terminator viruses (CTV): efficacious reagents for cancer gene therapy.
[16861924] Cell Cycle 5(14): 1531-6 (2006)

Targeting gene-virotherapy of cancer and its prosperity.
[17102812] Cell Res 16(11): 879-86 (2006)

Treatment of cancer with a novel dual-targeted conditionally replicative adenovirus armed with mda-7/IL-24 gene.
[18413837] Clin Cancer Res 14(8): 2450-7 (2008)

Oncolytic adenovirus-mediated MDA-7/IL-24 overexpression enhances antitumor activity in hepatocellular carcinoma cell lines.
[21134831] Hepatobiliary Pancreat Dis Int 9(6): 615-21 (2010)

Oncolytic adenovirus armed with IL-24 Inhibits the growth of breast cancer in vitro and in vivo.
[22640485] J Exp Clin Cancer Res 31(1): 51 (2012)

Interferon-alpha enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma.
[22569271] Mol Cancer 11(1): 31 (2012)

Adenoviral endoplasmic reticulum-targeted mda-7/interleukin-24 vector enhances human cancer cell killing.
[18723497] Mol Cancer Ther 7(8): 2528-35 (2008)

A serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels.
[21119025] Mol Pharmacol 79(3): 368-80 (2011)

Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant glioma.
[20179672] Mol Ther 18(6): 1130-42 (2010)

Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach.
[19888195] Mol Ther 18(2): 295-306 (2010)

Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo.
[12085234] Oncogene 21(29): 4558-66 (2002)

Targeting gene expression selectively in cancer cells by using the progression-elevated gene-3 promoter.
[15647352] Proc Natl Acad Sci U S A 102(4): 1059-64 (2005)

Oncolytic adenovirus SG600-IL24 selectively kills hepatocellular carcinoma cell lines.
[20872968] World J Gastroenterol 16(37): 4677-84 (2010)

Conditionally replicating adenoviruses carrying mda-7/IL-24 for cancer therapy.
[21995527] Acta Oncol 51(3): 285-92 (2012)

Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients.
[15585417] Mol Ther 11(1): 160-72 (2005)

Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study.
[15585416] Mol Ther 11(1): 149-59 (2005)

Targeting the tumor vasculature to improve the efficacy of oncolytic virus therapy.
[18042930] J Natl Cancer Inst 99(23): 1739-41 (2007)

Potential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer.
[22059911] Chin J Cancer 30(12): 805-14 (2011)

Future directions: oncolytic viruses.
[14967074] Clin Lung Cancer 5(4): 226-30 (2004)

Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter.
[19122384] Uirusu 58(1): 11-8 (2008)

Advances in oncolytic virus therapy for glioma.
[19149710] Recent Pat CNS Drug Discov 4(1): 1-13 (2009)

Intelligent design: combination therapy with oncolytic viruses.
[20029399] Mol Ther 18(2): 251-63 (2010)

Current issues and future directions of oncolytic adenoviruses.
[19935777] Mol Ther 18(2): 243-50 (2010)

Oncolytic viruses: an approved product on the horizon?
[20125160] Mol Ther 18(2): 233-4 (2010)

Herpes simplex virus oncolytic therapy for pediatric malignancies.
[19367259] Mol Ther 17(7): 1125-35 (2009)

Targeting cancer-initiating cells with oncolytic viruses.
[19672244] Mol Ther 17(10): 1677-82 (2009)

Adenoviral virotherapy for malignant brain tumors.
[19456208] Expert Opin Biol Ther 9(6): 737-47 (2009)

Oncolytic measles virus strains in the treatment of gliomas.
[18194077] Expert Opin Biol Ther 8(2): 213-20 (2008)

Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas.
[19860656] Curr Gene Ther 9(5): 422-7 (2009)

Stem cells as delivery vehicles for oncolytic adenoviral virotherapy.
[19860653] Curr Gene Ther 9(5): 389-95 (2009)

Mathematical modeling of tumor therapy with oncolytic viruses: regimes with complete tumor elimination within the framework of deterministic models.
[16542009] Biol Direct 1(-): 6 (2006)

The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon.
[19630549] Hum Gene Ther 20(10): 1119-32 (2009)

Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an overview.
[19169959] Curr Opin Mol Ther 11(1): 43-53 (2009)

Oncolytic adenoviruses targeted to cancer stem cells.
[19671759] Mol Cancer Ther 8(8): 2096-102 (2009)

A non-replicating oncolytic vector as a novel therapeutic tool against cancer.
[21189152] BMB Rep 43(12): 773-80 (2010)

The immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics.
[20832500] Microbes Infect 12(14-15): 1144-52 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Neoplasia (Oncolytic virus).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Neoplasia (Oncolytic virus).php on line 92